Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Corifollitropin alfa N02 in women of advanced reproductive age undergoing ART
CTR20261637Phase 4Active
- Sponsor
- Changchun GeneScience Pharmaceutical Co., Ltd.
- Start
- Apr 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of corifollitropin alfa in infertility, sponsored by Changchun GeneScience Pharmaceutical Co., Ltd.. Started Apr 2026; status: active.
02
Drugs
corifollitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on CTR20261637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20261637.